The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Varian Medical Systems Inc

NYSE: VAR
Last

(U.S.) $89.92

Today's change+0.44 +0.49%
Updated January 20 4:02 PM EST. Delayed by at least 15 minutes.
 

Varian Medical Systems Inc

NYSE: VAR
Last

(U.S.) $89.92

Today's change+0.44 +0.49%
Updated January 20 4:02 PM EST. Delayed by at least 15 minutes.

Varian Medical Systems Inc up (U.S.)$0.44

Varian Medical Systems Inc closed up Friday by (U.S.)$0.44 or 0.49% to (U.S.)$89.92. Shares have lost 0.84% for the last five days, but have gained 19.50% over the last 52 weeks. This security has underperformed the S&P 500 by 2.66% during the last year.

Key company metrics

  • Open(U.S.) $89.41
  • Previous close(U.S.) $89.48
  • High(U.S.) $90.00
  • Low(U.S.) $89.35
  • Bid / Ask-- / --
  • YTD % change+0.16%
  • Volume733,101
  • Average volume (10-day)833,266
  • Average volume (1-month)698,427
  • Average volume (3-month)835,070
  • 52-week range(U.S.) $73.18 to (U.S.) $106.70
  • Beta0.69
  • Trailing P/E21.42×
  • P/E 1 year forward18.72×
  • Forward PEG1.66×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $4.20
Updated January 20 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.51%

Based on its net profit margin of 12.51%, Varian Medical Systems Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.90%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jul 01, 201607/01/2016Apr 01, 201604/01/2016Jan 01, 201601/01/2016
Revenue912789759757
Total other revenue--------
Total revenue912789759757
Gross profit388346317310
Total cost of revenue525443442447
Total operating expense743659625640
Selling / general / administrative133153109140
Research & development66656260
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)17------
Other operating expenses, total--------
Operating income170130134117
Interest income (expense), net non-operating-3-3-3-2
Gain (loss) on sale of assets--------
Other--------
Income before tax171132135118
Income after tax118999789
Income tax, total53333829
Net income118999789
Total adjustments to net income--------
Net income before extra. items118999789
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items118999789
Inc. avail. to common incl. extra. items118999789
Diluted net income118999789
Dilution adjustment00--0
Diluted weighted average shares94959698
Diluted EPS excluding extraordinary itemsvalue per share1.241.041.010.91
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.371.041.010.91